GHK-Cu side effects according to the research
Across the published topical trials, GHK-Cu was well tolerated, with the odd case of mild skin irritation and no reported systemic adverse events. Copper toxicity is the theoretical worry at high exposure, but GHK-Cu's copper is tightly bound and delivered in microgram amounts. For injectable GHK-Cu there is no human safety data at all; that route is unstudied, not shown to be safe.
The topical safety record
GHK-Cu has featured in cosmetics for decades and shows up in the CIR (Cosmetic Ingredient Review) literature as safe at the concentrations used. The 12-week controlled facial studies reported no serious adverse events, with a small share of subjects noting passing redness or itching. Cosmetic use is permitted in Australia.
Copper
The body manages copper through ceruloplasmin and hepatic excretion, and GHK binds copper tightly enough that free-copper exposure from the peptide stays very low. A 50mg GHK-Cu vial holds about 8mg of copper in total, bound inside the complex. Human copper toxicity is tied to gram-scale ingestion or Wilson's disease, not to peptide-bound microgram exposure.
Injectable use: no human data
The record above is topical. No controlled human trial of injectable GHK-Cu has been published, so there is no data on systemic adverse events, injection-site reactions or long-term effects. A lack of data is not evidence of safety. Peptide Aus supplies GHK-Cu for in-vitro research and provides no guidance for use in people.
Cautions and interactions in the literature
In-vitro work indicates GHK-Cu can shift gene expression broadly, including genes tied to cell growth. Anyone working with proliferative cell lines should take that into account. No established drug interactions exist, because human systemic use has not been studied.
Frequently asked questions
Is GHK-Cu safe?
Topically, at cosmetic concentrations, the published record is good. For any other route, the safety data simply are not there.
Can GHK-Cu cause hair loss?
The research points the opposite way: larger follicles and a longer growth phase in models. No study has reported hair loss as an effect.
Does GHK-Cu cause cancer?
In cell studies, GHK-Cu turned down several genes associated with cancer progression. No study has tied it to causing cancer. Neither finding amounts to a clinical conclusion.
Kits
Build-Your-Own GLOW
GHK-Cu 50mg plus the BPC-157 + TB-500 blend, with water, forty syringes and swabs: GLOW's components as separate vials.
GHK-Cu Skin Pack (2 x 100mg)
Two GHK-Cu 100mg vials with water, sixty syringes and swabs, for longer skin and cellular protocols.
Related products
